Type of rheumatoid arthritis medication may be associated with increased risk for shingles

Use of certain medications known as monoclonal anti- tumor necrosis factor α (TNF-α) antibodies for the treatment of rheumatoid arthritis appears to be associated with an increased risk for herpes zoster (shingles), the painful infection characterized by blisters, according to a study in the February 18 issue of JAMA.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news154111170.html">Type of rheumatoid arthritis medication may be associated with increased risk for shingles</a></p> <p>Use of certain medications known as monoclonal anti- tumor necrosis factor α (TNF-α) antibodies for the treatment of rheumatoid arthritis appears to be associated with an increased risk for herpes zoster (shingles), the painful infection characterized by blisters, according to a study in the February 18 issue of JAMA.</p>